Valproic acid Completed Phase 2 Trials for Spinal Muscular Atrophy (SMA) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00227266Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
NCT00481013Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy